September 2008 – The CenterWatch Monthly : Volume 15, Issue 9, September, in PDF
Product Details
Central and Eastern Europe: Growth Opportunities, Growing Pains
Given the uneven length of global clinical trial experience in CEE countries, many industry insiders consider that the region has both emerging and “emerged” countries. Growth is expected to continue generally in the CEE region, perhaps more quickly in the largest countries, such as Russia and Ukraine.
No Fazing Phase I Growth
Phase I studies have become more complex as drug sponsors want critical data about their compounds to help inform decision-making and avoid expensive late-phase failures.
CRAcademy Offers New CRA Training Model in Europe
As most industry insiders will acknowledge, the clinical research employment market has undergone a shift—on a global scale—from being employer-driven to candidate-driven. Difficulties finding and keeping qualified clinical trials personnel in Europe and elsewhere have grown. Observers agree that the available workforce simply isn’t large enough to meet staffing needs. Experienced and inexperienced professionals alike are capitalizing on the clinical research industry’s staffing shortfalls.
Eye On: Allergies
Allergic reactions are defined as abnormal, excessive responses of the immune system in response to an otherwise harmless, foreign protein known as an allergen. Individuals who are genetically predisposed to a specific allergy or to multiple allergies mount an immune response via lymphocytes, immunoglobulinE (IgE) antibodies, inflammatory mediators and mast cells. This results in symptoms involving the target organs, namely, the nose, eyes, bronchial tubes, skin and gastrointestinal tract.
- Month in Review
- In the Pipeline
- Opportunities Underway
- TrialWatch